Conference item
CXCL13 levels in LGI1-and CASPR2-autoantibody syndromes
- Alternative title:
- Conference abstract
- Publication status:
- Published
- Peer review status:
- Reviewed (other)
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 63.7KB, Terms of use)
-
- Publication website:
- https://onlinelibrary.wiley.com/toc/14681331/2019/26/S1
Authors
- Publisher:
- Wiley
- Journal:
- European Journal of Neurology More from this journal
- Volume:
- 26
- Issue:
- S1
- Pages:
- 265
- Publication date:
- 2019-06-27
- Acceptance date:
- 2019-06-27
- Event title:
- 5th Congress of the European Academy of Neurology
- Event location:
- Oslo, Norway
- Event start date:
- 2019-06-29
- Event end date:
- 2019-07-02
- EISSN:
-
1468-1331
- ISSN:
-
1351-5101
- Language:
-
English
- Keywords:
- Pubs id:
-
pubs:1038292
- UUID:
-
uuid:22edee45-3755-41a5-9e5a-c7689b424e40
- Local pid:
-
pubs:1038292
- Source identifiers:
-
1038292
- Deposit date:
-
2019-11-17
- ARK identifier:
Terms of use
- Copyright holder:
- European Journal of Neurology
- Copyright date:
- 2019
- Rights statement:
- © 2019 European Journal of Neurology.
- Notes:
- This conference abstract was presented at the 5th Congress of the European Academy of Neurology, Oslo, Norway, 29 June- 2 July 2019. This is the accepted manuscript version of the abstract. The final version is available online from Wiley at: https://onlinelibrary.wiley.com/toc/14681331/2019/26/S1
If you are the owner of this record, you can report an update to it here: Report update to this record